News & Media

Adherence event series set to launch in Auckland this week

Professor Keith Petrie, Health Psychology Specialist, will discuss the importance of “getting into the minds of patients” in the first of a series of lectures, to support  the NZ healthcare market’s understanding on the issue of medication non-adherence, on the 2nd September in Auckland.

Read Full Article

   

Technology Development Grant Supports Expansion: Atlantis Healthcare

A $2 million Technology Development Grant will help support Atlantis Healthcare’s continuing expansion into new markets around the world, says Atlantis CEO Michael Whittaker.

Atlantis, which specialises in designing and delivering programmes that address the issue of medicines non-adherence, is one of 19 companies sharing a total of $52 million in grants from the Ministry of Science & Innovation’s business investment programme.

Read Full Article

   

AtlantisDigital provides the perfect complement

A new Digital Solutions division established by Atlantis Healthcare reflects the enormous opportunity innovative communication technology plays in the delivery of patient interventions in their patient support programmes.

Read Full Article

   

Adherence News Brief July 2011.

An international study involving more than 1,500 type 1 and type 2 diabetics has found one third of diabetes patients miss taking their insulin treatment an average three times a month, according to an article on Pharma Times Online.

 

Read Full Article

   

Podcast: Health Psychology and non-adherence

Posted by Andrew Tolve

Eye for pharma

Click here to access original posting and play

John Weinman, head of the department of health psychology at the Institute of Psychiatry, Kings College London, on how insights from health psychology can help improve patient compliance.

Read Full Article

   

New thinking needed to get the most out of adherence innovations

It is time for pharmaceutical companies and regulatory agencies to consider re-evaluating their systems and processes if they are to get the maximum benefit from the latest advances in medication adherence programmes, says Atlantis Healthcare’s Jonny Duder.

Read Full Article

   

Page 9 of 23